Keyphrases
COVID-19
100%
Matrix metalloproteinase-9 (MMP-9)
100%
Lung Damage
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
Angiotensin-converting Enzyme 2 (ACE2)
57%
Krebs Von Den Lungen-6 (KL-6)
57%
Leukocytes
42%
Neutrophil-lymphocyte Ratio
42%
Neutrophils
28%
Platelets
28%
Lymphocytes
28%
Monocytes
28%
Basophils
28%
Eosinophils
28%
Post-infection
28%
Platelet-to-lymphocyte Ratio
28%
Canonical Correlation
28%
Indonesia
14%
Surabaya
14%
Inflammation
14%
Two-level
14%
Disease Severity
14%
LISREL
14%
Confirmatory Factor Analysis
14%
University Hospital
14%
Neutrophil-lymphocyte
14%
Complete Blood Count
14%
Factor Value
14%
Infection Severity
14%
Loading Factor
14%
Covariance
14%
Clinical Infections
14%
IL-6/IL-10
14%
Damage Markers
14%
Nursing and Health Professions
Biological Marker
100%
Gelatinase B
100%
Lung Injury
100%
Diseases
100%
Metalloproteinase Inhibitor
100%
Angiotensin Converting Enzyme 2
57%
Infection
42%
Neutrophil Lymphocyte Ratio
42%
Platelet Lymphocyte Ratio
28%
Interleukin 10
14%
Confirmatory Factor Analysis
14%
Inflammation
14%
University Hospital
14%
Interleukin 6
14%
Blood Cell Count
14%
Disease Severity
14%
Covariance
14%
Pharmacology, Toxicology and Pharmaceutical Science
Coronavirinae
100%
Biological Marker
100%
Lung Injury
100%
Gelatinase B
100%
Diseases
100%
Metalloproteinase Inhibitor
100%
Angiotensin Converting Enzyme 2
57%
Infection
42%
Inflammation
14%
Interleukin 10
14%
Interleukin 6
14%
Disease Severity
14%